Activity of sunitinib in advanced malignant melanoma and its correlation with potential predictive biomarkers

@inproceedings{Decoster2010ActivityOS,
  title={Activity of sunitinib in advanced malignant melanoma and its correlation with potential predictive biomarkers},
  author={Lore Decoster and Bart Neyns and Isabelle Vande Broek and Ellen Anckaert and Dieter De Clerck and J. de Mey and Françoise Majois and J F Baurain and Hannelore Denys and J. P. De Greve},
  year={2010}
}
8518 Background: Sunitinib is a small molecule that inhibits several tyrosine kinase receptors, including VEGFR, PDGFR, c-KIT, FLT3 and RET. These kinases play a key role in neoangiogenesis and in ... 

Topics from this paper.

Similar Papers